Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.780
-0.040 (-0.83%)
At close: Jun 27, 2025, 4:00 PM
4.780
0.00 (0.00%)
After-hours: Jun 27, 2025, 7:52 PM EDT

Vanda Pharmaceuticals Market Cap

Vanda Pharmaceuticals has a market cap or net worth of $281.71 million as of June 27, 2025. Its market cap has decreased by -19.19% in one year.

Market Cap
281.71M
Enterprise Value
-47.46M
1-Year Change
-19.19%
Ranking
Category
Stock Price
$4.78

Market Cap Chart

Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $281.71M, an increase of 34.47%. That is a compound annual growth rate of 1.55%.

History

DateMarket Cap% Change
Jun 27, 2025281.70M0.86%
Dec 31, 2024279.30M15.03%
Dec 29, 2023242.80M-41.94%
Dec 30, 2022418.20M-52.16%
Dec 31, 2021874.10M21.64%
Dec 31, 2020718.60M-17.90%
Dec 31, 2019875.30M-36.13%
Dec 31, 20181.37B100.69%
Dec 29, 2017682.90M-2.57%
Dec 30, 2016700.90M75.84%
Dec 31, 2015398.60M-17.90%
Dec 31, 2014485.50M17.87%
Dec 31, 2013411.90M294.54%
Dec 31, 2012104.40M-21.97%
Dec 30, 2011133.80M-49.57%
Dec 31, 2010265.30M-13.30%
Dec 31, 2009306.00M2,200.75%
Dec 31, 200813.30M-92.75%
Dec 31, 2007183.40M-66.04%
Dec 29, 2006540.00M157.76%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 711.28B
Johnson & Johnson 366.40B
AbbVie 327.47B
Novo Nordisk 301.06B
UnitedHealth Group 273.97B
Abbott Laboratories 239.05B
Novartis AG 231.01B
AstraZeneca 216.45B
Market Cap Rankings